• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Optimize EP Launches CaRM Cardiac Device Data Management Platform

    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030

    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR

    Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation

    Moon Surgical Expands Leadership Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Unicep

    K-Tube Technologies

    PTI Engineered Plastics Inc.

    Spectrum Plastics Group

    Element
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Spectrum Plastics Group

    Medbio LLC

    Qosina Corp.

    maxon

    Creganna Medical, part of TE Connectivity
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Features

    Designing from Finish to Start

    When developing products for a value-based environment, it can be helpful to consider the end result first.

    Designing from Finish to Start
    Related CONTENT
    • CMS Expedites Breakthrough Device Access; Industry Applauds
    • Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    • Vonco Products Receives ISO 13485:2016 Certification
    • BioSerenity Achieves FDA Clearance for Wearable Device System
    • Greenlight Guru and Nelson Labs Partner
    Steve Maylish and Vicki Caiati05.03.18
    In 2007, the Institute for Healthcare Improvement developed the Triple Aim: to simultaneously improve patient experience and population health, while also lowering cost per capita. This influenced the 2010 Affordable Care Act (ACA). In 2015, the Medicare Access and CHIP Reauthorization Act (MACRA) was passed and in October 2016, the Centers for Medicare and Medicaid Services (CMS) issued the final rule to implement MACRA. Its intent is to reduce healthcare spending and overall utilization by incentivizing providers to improve quality and outcomes. Today, our healthcare model is in the process of changing from volume based to value based. In 2018, if you’re designing a product with a fee-for-service model in mind, you may be on very thin ice.

    Currently, about 30 percent of all healthcare payments in the U.S. are tied to alternative payment models (APMs), according to an Oct. 30, 2017, report from the Health Care Payment Learning & Action Network. In just over five years, APM payments are expected to be close to 80 percent. MACRA and ACA are driving APMs and value-based care. Starting in 2019, MACRA will pay Medicare reimbursement to clinicians based on performance.

    According to an analysis done by Deloitte, “MACRA overhauls Medicare’s payments to clinicians by creating strong incentives for them to participate in APMs that require financial risk-sharing…designed to improve quality. Clinicians who are not counted as participating in these models will need to report and have their performance measured in four categories—quality, resource use, health information technology (HIT) use, and clinical practice improvement.” Resource use, which measures costs associated with clinicians’ practice and referral patterns, will increase in importance over time (0 percent in 2017, 10 percent in 2019, and 30 percent in 2021). Physicians will then be compared to their peers and either have a reimbursement incentive, no adjustment, or a penalty assessed (±4 percent in 2019, ±5 percent in 2020, ±7 percent in 2021, and ±9 percent in 2021).

    The ACA as well as numerous health reform initiatives such as Value-Based Purchasing, Accountable Care Organizations, Pay for Performance, Hospital or Physician Bundled Payments, and others have required hospitals and integrated delivery networks (IDNs—a system of providers) to take a more systematic and evidenced-based approach to new product adoption.

    Currently, most of the healthcare system works on a fee-for-service model and volume-based purchasing. CMS found from 2013 to 2022, group purchasing organizations are expected to generate volume-based savings of up to $864 billion for the U.S. health system. But volume can only bend the cost curve so far and buying on price can negatively affect outcomes. That’s where value-based models come into play.

    Hospitals and IDNs are now wrestling with the problem of value (costs and outcomes), but many device companies continue to focus on new technology and incremental benefits. Pay-per-click revenue models have allowed device-only companies to create a “disposable-like” revenue stream. While it may avoid some capital expense up front, many of these devices are costlier in the long run. Point-of-care microfluidic devices have moved diagnostic tests closer to the patient and decreased time-to-result, but often tests cost more and rapid results are not necessary.

    It’s important to understand that hospitals are in a difficult situation, caused by increasing demand and decreasing reimbursement. To make matters worse, the U.S. healthcare system is an outlier, far outspending others but ranked last among high-income countries. As hospitals focus on lowering operating and supply costs, they are not able to cut their way to profitability. At the same time, demand for improved patient outcomes and satisfaction continues. Therefore, new technologies will be evaluated on their impact to the patient and the bottom line. This includes areas of opportunity like increased reimbursement, productivity, workflow, or operational benefits, if linked to significant savings or revenue.

    As opposed to the fee-for-service model, APMs include: Bundled Payments for Care Improvement such as paying one fee for a joint replacement, which aligns hospitals, health systems, and physicians; Pay for Performance such as paying a bonus in addition to the fee-for-service once the provider meets certain quality goals (eventually to include financial disincentives); Shared Savings/Risk such as a contract between providers and payers that holds them collectively responsible for the total expense of a given patient population, and Accountable Care Organizations created through the ACA to pay a network of physicians, hospitals, and healthcare providers to share responsibility for coordinating care and meeting quality and cost goals.

    It’s important to note that there are many risk-sharing models, some more effective than others, but all are converging on lower cost, improved performance, and better outcomes by sharing financial risk. Implementing IT systems for reporting/analyzing data are an integral part of these new measures and can be expensive to implement, especially for smaller independent or private physician organizations. Therefore, ACA and MACRA are also driving “macro” changes in the healthcare environment.

    Macro Healthcare Environment
    • Consolidation of healthcare networks and insurance companies
    • Hospitals employing private physician practices
    • Private physician practices merging with physician hospital organizations
    • University medical centers affiliating with clinics, hospitals, and physician associations
    • Healthcare provider organizations becoming payers
    • Payer-to-employer health insurance models shifting to payer-to-consumer
    • Payers looking to shift risk to healthcare providers
    • Rapid growth in websites offering hospital rating and benchmarking services
    • Physicians having to report personal quality measures
    • Larger number of patients covered by Medicare/Medicaid

    How does this affect medical device companies and the way they design products? With APMs and other value-based drivers, the rules of the game have changed. Medical device companies must understand the new rules to deliver the right products or appropriate services. Companies should supply real-world evidence to prove out the value of their products. No longer can physicians or nurses make purchasing decisions without involving other departments in their hospitals, practices, or organizations.

    Before getting into the details of the purchasing process within a hospital, let’s consider how a product gets developed. Once a company has a medical device concept in mind and marketing requirements on paper, the value proposition should embrace the Triple Aim, not just device features and benefits. In the best case, a clinical solution should ultimately lower cost, improve performance, and provide better patient outcomes. Innovation is no longer an end in itself and clinician preference no longer drives sales.

    The larger the overall impact and the more dramatic the clinical outcomes, the better the value proposition is. To be compelling, the value proposition has to address the goals of the provider. It should link the product or service to measurable outcomes and clear financial impact.

    Value Proposition Considerations
    • Increase revenue for hospital
    • Maximize reimbursement
    • Lower overall costs
    • Increase survivability for patients
    • Increase outcomes over existing products
    • Reduce infection rates or hospital-acquired conditions
    • Increase patient satisfaction
    • Improve patient health or quality of life
    • Reduce length of stay (LOS)
    • Reduce complications or increase predictable outcomes
    • Reduce readmission rates
    • Reduce admission or discharge costs
    • Increase patient throughput
    • Increase productivity or standardization
    • Provide actionable data

    Some medical devices require clinical trials for FDA approval while others do not. Without clinical trials, a medical device company may have a quicker path to commercialization and look more attractive to investors. This may be counter-productive to a value analysis, however. Without clinical trials or real-world evidence, a new technology may not be evaluated by providers.
    New products should answer the questions in Figure 1. If any answer is no, reevaluation is warranted.


    Figure 1: A new medical device product should generate a positive response for each of the questions. If any answer results in a negative response, a reevaluation should be conducted.

    Consider a single-use diagnostic cystoscope, designed to visually assess the female urethra and urinary bladder for suspected pathology or dysfunction. The device is a self-contained, single-use diagnostic scope. It’s lightweight, portable, and battery powered with a disposable cannula and a reusable handle, which includes a display.

    After the company completed a clinical study, the group of 12 providers in the study made the decision to adopt. They found significant advantages clinically and economically over reusable scopes with single-use sheaths: safer for patient, less discomfort, easier to use, overall decreased cost to provider, faster turnover of procedure room, better visualization, less risk of scope malfunction or infection, and ability to show findings in real time to patients. This product meets the Triple Aim, allowing the provider and perhaps the payer to share financial savings.

    But sometimes value can be more difficult to prove. Consider the bariatric balloon, designed for weight reduction. Most patients see great results, losing about 30 percent of their excess weight in six months (when the balloon is removed). As with many weight reduction plans, the key is to keep the weight off afterwards. Bariatric-surgery-source.com states that “Unless you establish and maintain a proper diet and exercise program or transition to a more involved bariatric surgery, you will regain all of your weight when your balloon is removed.”

    As opposed to the cystoscope, gastric balloons are not for everyone. Therefore, the number needed to treat (NNT) or the number of patients that need to be treated for one of them to benefit (over a control group), is higher. For arguments sake, let’s say the number is two. Therefore, for every two people treated, one receives the desired weight loss. Payers will not reimburse for a procedure or product if the NNT is too high. Benefit has to outweigh cost.

    If you add in the number of patients who regain their weight despite nutritional and fitness counseling afterwards, the NNT continues to rise. The procedure itself is certainly less invasive than other forms of bariatric surgery so there should be improved patient experience. In this example, however, the outcomes are unclear.

    If this is not complicated enough, consider back pain. Ignoring issues with excessive imaging and opioids, a retrospective paper completed after the late 1990s run-up in spine fusion surgery noted that, “Although spine fusion surgery has a well-established role…its benefit is more limited when treating degenerative discs with back pain alone…Multiple randomized trials suggest that adding surgical implants to bone grafting slightly improves rates of solid bone fusion, but may not improve pain or function…Instead of measuring only technical success, studies should clarify a treatment’s safety and its effects on pain, function, and return to work.”

    A great example of spine surgery improvement was the introduction of the K-wire, cannulated screws, and the minimally invasive surgery it enabled. Reducing cost and improving outcomes should be the new design goal, while safety and efficacy are the new baseline.

    It’s imperative for medical device companies to clearly articulate the problem that the hospital is facing, and develop a strong value proposition supported by clinical and economic data. If there is an opportunity to work with physician societies and key opinion leaders to help update or create clinical guidelines, this will also positively support use of the product or service. Companies that have an excellent understanding of the value analysis committee (VAC) process can respond to the needs of individual hospital or hospital system committees.

    While earlier value analysis efforts focused more on cost-cutting measures and standardization of product use within the hospital, there is now emphasis on measuring and attaining improved quality of delivery and clinical outcomes. Formalized internal hospital teams—often called a value analysis committee, new product committee, or technology assessment committee—now have even greater impact on the evaluation of a new technology or product.

    Getting a product through a value analysis committee typically takes three to six months. Having the sales representative understand how the process works within each of their accounts is crucial as they differ from hospital to hospital.

    Responsibilities of committee members on VAC teams vary greatly, but generally, there are both clinical leaders on the team to provide input on clinical and product use and administrative leaders on the team, which may include representatives from supply chain, finance, quality, risk management, and/or infection control. There can be vast differences between hospitals and IDNs on number of members, roles of committee members, meeting frequency, and level of involvement expected from its members.

    Initiating the VAC process typically starts with submitting a New Product Request Form to the hospital or IDN. These forms are always required, but the specific forms and information requested vary from place to place, except in the case of forms that might be standardized within a hospital system. These are typically submitted to the hospital by a product champion (doctor or nurse) that is interested in using the new product. Common information expected is:
    • Vendor information
    • Implementation/training plans
    • Product information (packaging, ordering details, disposal or reprocessing requirements)
    • Supporting clinical resources
    • Data

    Company representatives are rarely allowed to participate in VAC meetings, so the company needs to prepare someone from the hospital to represent their product. It’s imperative to select a person with the power, influence, and available time to promote the product well. Companies will need to coach the product champion to best represent them and ensure they know how to deal with common objections. Make sure they fully understand the information and can effectively communicate it to others.

    The sales representative should know all of the participants in the VAC process within an account. If possible and allowed by the hospital, sales should meet with them prior to the committee meeting to provide information and answer any questions.

    Committees consist of a variety of people with different interests who evaluate potential new products. Delivering a large volume of information with no guide or instructions may be even worse than providing too little information. What has worked well in the past is providing one physical product folder and one USB drive for each VAC member. Detailed information within the folder will be directed to the individual committee members (e.g., clinical, financial, safety related) so they can access the most relevant materials for their specific area of interest.

    A tool kit can be developed for the product specifically designed to support the VAC process. It should include an overview of the clinical problem and an explanation of how the product is a solution. Cost calculators, 510(k) clearance, ordering and use information, product brochure, educational materials, pricing information, product warranty information, reimbursement/coding/billing information, videos, key clinical papers and posters, product implementation/training support details, and information on clinical trials and other real-world data relating to the product should be included. Further, ensure the product champion knows what is included so they can direct team members to the relevant information.

    Remember, VAC members are interested in innovative concepts that improve care and outcomes at less cost. How will it be implemented into the hospital setting, information systems, electronic health records, emergency department, or lab information systems? Could the device transform care delivery or significantly reduce financial risk? Once implemented, will the efficiencies be self-evident or require additional data and analysis?

    Consider how the product could collaborate with another to improve efficiencies. Can the technology interface with a wearable device or smart phone? Can it be connected to cloud computing or be remotely monitored? Does the device improve CMS metrics, such as hospital-acquired infections, lengths of stay, or readmission rates? Can it transform inpatient procedures to outpatient? Does the technology provide independence for the elderly, prevent injuries, or delay onset of disease?

    Design Considerations
    • Lower cost and improve the standard of care
    • Decrease complications, infections, readmissions, or hospital-acquired conditions
    • Reduce skill required or provide earlier point of intervention
    • Introduce a new care delivery platform
    • Increase efficiency or throughput with minimal operational costs
    • Provide a less invasive, less intensive, less complicated procedure to reduce LOS
    • Improve quality of data, data analysis, or data reporting to the hospital information system, electronic health record, emergency department, laboratory information system, etc.
    • Solve a regulatory or reporting issue and reduce risk or liability

    Hospitals and integrated delivery networks, by necessity, are focusing more on economics, patient satisfaction, information technology, transparency, and preventive and primary care. Although alternative payment models, like bundled payments, should move providers away from fee-for-service, it may not work well for high-risk patients. Therefore, expect models to evolve. But, it’s clear that value-based care is the new direction in healthcare. As the hurdle gets higher and higher for medical device companies, those willing to design with the end in mind and provide value-based products should find numerous opportunities, not least among them being the opportunity to improve patient’s lives. As the healthcare ecosystem works to improve outcomes and lower costs, all will benefit. 


    Steve Maylish has been part of the medical device community for more than 30 years. He is currently chief commercial officer for Fusion Biotec, an Orange, Calif.-based contract engineering firm that brings together art, science, and engineering to create medical devices. Early in his career, Maylish held positions at Fortune 100 corporations such as Johnson & Johnson, Shiley, Sorin Group, Baxter Healthcare, and Edwards Lifesciences.

    Vicki Caiati has extensive experience with developing and executing strategy for medical devices in mature markets as well as for new clinical therapies. She has held sales, marketing, and training leadership positions with ClearFlow, Alsius/Zoll, B. Braun, Smiths Medical, Shiley Cardiovascular, and AACN (American Association of Critical Care Nurses). She currently supports both large and small companies with consulting/contract work on a variety of marketing and sales projects.
    Related Searches
    • johnson
    • regulatory
    • 2013
    • wearable
    Related Knowledge Center
    • R&D & Design
    Suggested For You
    Perspectives on Post-Pandemic: Consider the IT Infrastructure Perspectives on Post-Pandemic: Consider the IT Infrastructure
    Perspectives on Post-Pandemic: Expect Supply Chain Security to Increase Perspectives on Post-Pandemic: Expect Supply Chain Security to Increase
    Medtech Matters: Medtronic Medtech Matters: Medtronic's Robotic Surgery Status
    Medtech Matters: Surgeons Scrubbing In Virtually Medtech Matters: Surgeons Scrubbing In Virtually
    CMS Expedites Breakthrough Device Access; Industry Applauds CMS Expedites Breakthrough Device Access; Industry Applauds
    Medtech Matters: Talking Robotic Surgery with Zimmer Biomet Medtech Matters: Talking Robotic Surgery with Zimmer Biomet
    Vonco Products Receives ISO 13485:2016 Certification Vonco Products Receives ISO 13485:2016 Certification
    BioSerenity Achieves FDA Clearance for Wearable Device System BioSerenity Achieves FDA Clearance for Wearable Device System
    Greenlight Guru and Nelson Labs Partner Greenlight Guru and Nelson Labs Partner
    Katena Products Welcomes New CEO Katena Products Welcomes New CEO
    Medtech Veteran Joins VivaLNK Board Medtech Veteran Joins VivaLNK Board
    New Company Formed to Develop Peripheral Venous Disease Treatments New Company Formed to Develop Peripheral Venous Disease Treatments
    New Global Headquarters for Freudenberg Medical New Global Headquarters for Freudenberg Medical
    4D Biomaterials Awarded Funding for 3D Tissue Scaffolds 4D Biomaterials Awarded Funding for 3D Tissue Scaffolds
    Medtronic’s Mike Coyle to Lead iRhythm Medtronic’s Mike Coyle to Lead iRhythm

    Related Features

    • R&D & Design
      The Human Factors of Aesthetics

      The Human Factors of Aesthetics

      Exploring the relationship between a device’s aesthetic, human factors engineering, and purposeful design.
      Sean Hägen, Principal, Director of Research & Synthesis, BlackHägen Design 09.01.20

    • R&D & Design
      Current State of (Design) Mind

      Current State of (Design) Mind

      Medtech designers have an array of new tools to use for medical device development, enabling better solutions for healthcare.
      Mark Crawford, Contributing Writer 05.01.20

    • R&D & Design
      Examining the Usability of Medical Software

      Examining the Usability of Medical Software

      Developers need to consider the ‘human factor’ when it comes to testing medical device software.
      Bruce Johnston, Senior Software Engineering Specialist, MedAcuity Software 04.01.20


    • R&D & Design
      Four Considerations for Developers of Next-Generation Combination Products

      Four Considerations for Developers of Next-Generation Combination Products

      Bringing together real-time monitoring, telemedicine, AI, interventions, and pharmaceuticals into a single device produces a number of potential pitfalls.
      Mark Goodman and Barry Thompson, Baker & McKenzie LLP 03.04.20

    • R&D & Design
      Inventive Interaction: Medtech Research and Development in 2020

      Inventive Interaction: Medtech Research and Development in 2020

      Engaging with all stakeholders—patients, clinicians, and community members alike—is key to effective medtech R&D.
      Michael Barbella, Managing Editor 01.29.20

    • Contract Manufacturing | Materials | R&D & Design
      Delivering the Goods: The Evolving World of Combination Products

      Delivering the Goods: The Evolving World of Combination Products

      This extremely diverse market fosters relationships between medical device and pharmaceutical companies.
      Sam Brusco, Associate Editor 11.04.19


    • Cardiovascular | Contract Manufacturing | Diagnostics | Digital Health | Electronics | Neurological | Patient Monitoring | R&D & Design
      Customized Connections: A Discussion on Custom Electronics

      Customized Connections: A Discussion on Custom Electronics

      Demand for more complex, traceable, integrated solutions are driving innovation in the fast-changing medical electronics market.
      Michael Barbella, Managing Editor 09.09.19

    • R&D & Design
      Consumer-Minded Design

      Consumer-Minded Design

      OEMs are requiring design partners to put more focus on user interface and aesthetics as they seek to produce devices intended to be used directly by patients.
      Mark Crawford , Contributing Writer 05.01.19

    • R&D & Design | Software & IT | Testing
      Transformative Testing: Addressing Patient Safety and Cybersecurity

      Transformative Testing: Addressing Patient Safety and Cybersecurity

      With changing regulatory landscapes and requirements, testing providers are being asked to do more in terms of ensuring the safety of medical devices.
      Mark Crawford, Contributing Writer 03.07.19


    • Materials | R&D & Design
      Sum and Substance: Material Considerations for Changing Design Needs

      Sum and Substance: Material Considerations for Changing Design Needs

      Material science and medical device development have a symbiotic relationship; advancement in one encourages innovation in the other.
      Sam Brusco, Associate Editor 03.07.19

    • R&D & Design
      Valued R&D: The Transformation of Medical Device Research and Development

      Valued R&D: The Transformation of Medical Device Research and Development

      Rising healthcare costs, limited reimbursements, and the pace of technological change is forcing medtech companies to find creative R&D solutions.
      Michael Barbella, Managing Editor 01.30.19

    • Contract Manufacturing | Machining & Laser Processing | Molding | Packaging & Sterilization | R&D & Design | Testing | Tubing & Extrusion
      Addressing Peak Issues in Medtech

      Addressing Peak Issues in Medtech

      The 2018 MPO Summit heads to Colorado for discussion, education, and networking.
      Sean Fenske, Editor-in-Chief 07.26.18


    • R&D & Design
      The DNA of Emotional Design

      The DNA of Emotional Design

      Designing user experiences to optimize the clinical team’s performance.
      Bryce G Rutter, Ph.D., Founder & CEO, Metaphase Design Group Inc. 07.26.18

    • R&D & Design
      R&D Reboot: Leveraging New Strategies for Innovation Creation

      R&D Reboot: Leveraging New Strategies for Innovation Creation

      Medtech companies must adopt new research and development models to remain relevant and competitive in an evolving healthcare
      Michael Barbella, Managing Editor 01.29.18

    • Contract Manufacturing | R&D & Design
      An Outsourcing Focus in San Diego

      An Outsourcing Focus in San Diego

      The MPO Summit travels to southern California for sun, surf, networking, and industry insights.
      Sean Fenske, Editor 07.26.17


    Trending
    • Cytotron Gains Breakthrough Status To Treat Breast, Liver, And Pancreatic Cancers
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • 5 Ways Plastics Revolutionized The Healthcare Industry
    • Hardy Diagnostics Releases Rapid Test For COVID-19
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • Optimize EP Launches CaRM Cardiac Device Data Management Platform
    • U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    • FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    • Cognito Therapeutics’ Lead Product Receives FDA Breakthrough Device Designation
    • Moon Surgical Expands Leadership Team
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Brown Fat Associated with Reductions in Chronic Disease Risk
    NIH Study Identifies Antibacterial Properties in Taurine
    NSF Begins New Certification Program
    Coatings World

    Latest Breaking News From Coatings World

    Zeppelin Acquires MTI Mischtechnik
    Ezio Braggio Joins ChemQuest Europe
    IFS Coatings Announce Carbon Offset Program
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Optimize EP Launches CaRM Cardiac Device Data Management Platform
    U.S. TAVR Market Projected to Reach Nearly $5 Billion by 2030
    FDA Clears Canon Medical's Compressed SPEEDER for 3D Exams on 1.5T MR
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    Frontage Bolsters Clinical Services Capabilities
    Sanofi Unveils EUROAPI as Name of New European API Company
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Neenah to Host Packaging Webinar for Printers
    W.S. Badger is Named a ‘150 Top Impact Company’
    Mana Products, Meiyume and RPG Form The Vertical Beauty Alliance
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    P&G, L'Oréal & Amorepacific Make News at CES
    Three Form Vertical Beauty Alliance
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Shemesh Adds U.S. Headquarters
    TZMO USA, Special Needs Group Form Partnership
    BAHP Announces 2021 Officers, Board of Directors
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Boston Scientific Releases WaveWriter Alpha Spinal Cord Stimulators in U.S.
    New Chief Clinical Officer on Board at IncludeHealth
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Toppan Announces 2050 Environmental Vision
    SOI Industry Consortium Joins SEMI as Strategic Association Partner

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login